AverellHirschSherkerMD

Gastroenterology • Bethesda, MD

Hepatology & Liver Transplantation

Associate Professor, Medicine, Georgetown University School of Medicine

Join to view full profile

Dr. Sherker is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Sherker's full profile

Already have an account?

Office
6707 Democracy
Bethesda, MD 20817

Education & Training

Queen's University at KingstonClass of 1982

Certifications & Licensure

CA State Medical License 1989 - 2026
DC State Medical License 2001 - 2024
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Gastroenterology

Clinical Trials

A Randomized, Double-Blinded, Placebo-Controlled Trial of Corticosteroid Therapy Following Portoenterostomy Start of enrollment: 2005 Nov 01
Completed
Not Applicable
Prediction by Ultrasound of the Risk of Hepatic Cirrhosis in Cystic Fibrosis Start of enrollment: 2010 Jan 12
Completed
Multi-Center African-American Inflammatory Bowel Disease Study (MAAIS) Start of enrollment: 2003 Jun 01
Recruiting
Combination Entecavir and Peginterferon Therapy in HBeAg-Positive Immune-Tolerant Adults With Chronic Hepatitis B Start of enrollment: 2012 May 01
Terminated
Phase 3
A2ALL-Patients Safety System Improvements in Living Donor Liver Transplantation Start of enrollment: 2010 Oct 01
Completed
MRI to Characterize and Predict CF Liver Disease in PUSH Cohort Start of enrollment: 2017 Jan 27
Completed
Longitudinal Assessment of Transient Elastography in Cystic Fibrosis Start of enrollment: 2017 Mar 08
Completed
Join now to see all

Publications & Presentations

PubMed

Investigation of the Role of Chemical Analysis in Causality Assessment of Herbal and Dietary Supplement-Induced Liver Injury.
Dina Halegoua-DeMarzio, Victor J Navarro, Ashley Davis, Jawad Ahmad, Bharathi Avula
Drug Safety. 2024-10-01
1 citations
In NASH with liver fibrosis, resmetirom improved NASH resolution and reduced fibrosis at 1 y.
Maria Mironova, Averell H Sherker
Annals of Internal Medicine. 2024-06-01
8 citations
Chronic Hepatitis Is Common and Often Untreated Among Children with Hepatitis B Infection in the United States and Canada.
Simon C. Ling, Hsing-Hua S Lin, Karen F. Murray, Philip J. Rosenthal, Douglas Mogul
The Journal of Pediatrics. 2021-10-01

Press Mentions

Steroids After Surgery Do Not Help Infants with Rare Liver DiseaseMay 4th, 2014